ACM
AERI

Asymmetry Capital Management’s Aerie Pharmaceuticals AERI Stock Holding History

Asymmetry Capital Management’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-62,507
Closed -$1.51M – 40
2019
Q4 		$1.51M Buy
+62,507
New +$1.29M 2.71% 15
2019
Q2 		– Sell
-71,675
Closed -$3.4M – 37
2019
Q1 		$3.4M Buy
71,675
+14,189
+25% +$625K 5.69% 7
2018
Q4 		$2.08M Sell
57,486
-15,484
-21% -$726K 5.73% 5
2018
Q3 		$4.49M Buy
72,970
+23,214
+47% +$1.49M 4.15% 6
2018
Q2 		$3.36M Sell
49,756
-19,920
-29% -$1.11M 3.3% 10
2018
Q1 		$3.78M Buy
69,676
+29,346
+73% +$1.64M 4.73% 5
2017
Q4 		$2.41M Buy
40,330
+22,355
+124% +$1.36M 3.27% 10
2017
Q3 		$874K Sell
17,975
-7,489
-29% -$409K 1.01% 29
2017
Q2 		$1.34M Sell
25,464
-23,336
-48% -$1.09M 1.59% 23
2017
Q1 		$2.21M Sell
48,800
-15,295
-24% -$682K 3.09% 15
2016
Q4 		$2.43M Sell
64,095
-86,556
-57% -$3.27M 4.51% 11
2016
Q3 		$5.69M Buy
150,651
+66,625
+79% +$1.47M 9.89% 2
2016
Q2 		$1.48M Sell
84,026
-56,561
-40% -$916K 2.71% 15
2016
Q1 		$1.71M Buy
140,587
+54,692
+64% +$865K 4.46% 10
2015
Q4 		$2.09M Buy
85,895
+61
+0.1% +$1.42K 3.16% 13
2015
Q3 		$1.52M Buy
+85,834
New +$1.55M 3.39% 13

Other funds holding AERI

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.49B AUM 30.44% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

Asymmetry Capital Management's AERI Position: Q1 2020 in Review

Asymmetry Capital Management sold out of Aerie Pharmaceuticals (AERI) in Q1 2020, closing a stake of 62,507 shares — an estimated $1.51M sold.

Asymmetry Capital Management first reported a position in AERI in Q3 2015 and held it in 16 quarters. The position peaked at $5.69M in Q3 2016. 155 funds tracked by Wall St. Rank hold AERI as of Q1 2020.

  • Asymmetry Capital Management reported no remaining Aerie Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • Asymmetry Capital Management sold 62,507 Aerie Pharmaceuticals shares in Q1 2020, an estimated $1.51M.
  • Asymmetry Capital Management first reported a position in Aerie Pharmaceuticals in Q3 2015 and held it in 16 quarters.
  • Asymmetry Capital Management's Aerie Pharmaceuticals position peaked at $5.69M in Q3 2016.
  • 155 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q1 2020.

Based on Asymmetry Capital Management's 13F filing for Q1 2020, filed 13 May 2020.